TD Cowen on Evolent Health (EVH): 'Share Weakness Is Overdone'
Tweet Send to a Friend
TD Cowen analyst Charles Rhyee reiterated a Buy rating and $8.00 price target on Evolent Health (NYSE: EVH).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
